Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC.
Advertisements

Bioequivalence Studies Anoop Agarwal
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
6/10/20151Prof. Mazen Qato. Objectives At the end of this sessions students should be able to: 1. List and discuss common routes of drug administration.
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
Pharmacokinetics Chapter 4.
Roselyn Aperocho-Naranjo Pharmacy Instructor USPF, College of Pharmacy
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering Universiti Malaysia Perlis.
PHARMACEUTICAL INDUSTRY Drug Discovery - natural sources, synthesis/modification Preclinical Studies biological properties - pharmacology, pharmacokinetics.
10/1/20151 BIOPHARMACEUTICS, NEW DRUG DELIVERY SYSTEMS & DEVICES A. S. Adebayo, Ph.D.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
Clinical Pharmacokinetics. Clinical Pharmacodynamics. Drugs’ Interaction. Adverse Effects of Drugs.
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
Week 6- Bioavailability and Bioequivalence
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
Orientation to Pharmacology
October 22, EFFECT OF PHYSICO- CHEMICAL PROPERTIES OF DRUG ON ABSORPTION By Dr. A. S. Adebayo.
Formulation factors By Dr. A. S. Adebayo.
Bioavailability Dr Mohammad Issa.
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Biopharmaceutics refers to the relationship of the:
1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
CHAPTER 7 ABSORPTION KINETICS.
Pharmacology Department
The Biopharmaceutical Classification System (BCS)
INTRODUCTION CLINICAL PHARMACOKINETICS
Introduction of Biopharmaceutics and Pharmacokinetics
Introduction What is a Biowaiver?
Bioavailability and Bioequivalence General concepts and overview
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.
Lecture 7 PHARMACOKINETICS
PHT 415 BASIC PHARMACOKINETICS
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
415 PHT Plasma Level – Time Curve
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
Foundation Knowledge and Skills
Definitions and Concepts
Drug Response Relationships
The Biopharmaceutical Classification System (BCS)
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Pharmacology I BMS 242 Lecture II (Continued)
Life Span Consideration
CHAPTER 7 ABSORPTION KINETICS.
Introduction What is a Biowaiver?
Gastrointestinal Absorption: Role of the Dosage Form
Biopharmaceutics of modified release drug products
Biopharmaceutics factors affecting Modified release products
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Quantitative Pharmacokinetics
Biopharmaceutic Considerations in Drug Product Design
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
Factors Affecting Drug Absorption (Dosage form factor)
Introduction to Pharmacology
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Basic Biopharmaceutics
Pharmacologic Principles (Lilley, p. 16)
Biopharmaceutics 4th year
Formulation factors By Dr. A. S. Adebayo.
Presentation transcript:

Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas

 “The rate & extent to which the active ingredient or active moiety is absorbed from a drug product & becomes available at the site of action  Usually estimated by its concentration in body fluids, pharmacologic response, clinical response, the rate & extent of excretion

 Concerned with how quickly & how much of a drug appears in the blood after a specific dose is administered  The BA of a drug product often determines the therapeutic efficacy of that product since it affects the onset, intensity & duration of therapeutic response of the drug.

Absolute & Relative BA  Determination of absolute BA of a drug usually involves a comparison of AUC obtained following extravascular & IV administration of the drug  Relative BA is obtained by comparing the AUCs when like or unlike dosage forms of the same drug are administered by same or different routes but not iv.

Absorption  Occurs after its release from the dosage form. Release of drug depends on the physical & chemical properties of the drug, the dosage form (delivery system), the site & route of administration.  The physical & chemical characteristics of a drug as well as its formulation are of prime importance in BA because they can affect not only the absorption characteristics of the drug but also its stability.

 Since a drug must be dissolved to be absorbed, its rate of dissolution from a given product must influence its rate of absorption, the onset, & could affect the pharmacologic activity of a drug.  Factors that affects the dissolution rate of slowly dissolving substances is the surface area of the dissolving solid  After the administration of a drug solution, or following the dissolution of a solid dosage form, drug molecules enter into the systemic circulation by crossing one or more biological membranes.

Absorption  Effects of formulation & processing variables on the dissolution of active ingredients from drug products; an apparently inert ingredient may affect drug absorption.  The nature of the dosage form itself may have an effect on drug absorption characteristics. Fastest availability Slowest availability Solutions Suspensions Capsules Tablets Coated tablets Controlled-release formulations

 BA Factors related to the dosage form Physicochemical properties of the drug Formulation & manufacturing variables Particle size Crystalline structure Degree of hydration of crystal Salt or ester form Amount of disintegrant Amount of lubricant Special coatings Nature of diluent Compression force

Factors influence the BA of a drug  BA Factors Related to the patient Physiologic factorsInteractions with other substances Variations in absorption power along GI tract Variations in pH of GI fluids Gastric emptying rate Intestinal motility Perfusion of GIT Presystemic & first-pass metabolism Age, sex, weight Disease states Food Fluid volume Other drugs

Sequence of events after administration of a drug product Method of evaluationExample Dissolution at administration or absorption site Dissolution rateIn vitro: water, buffer, artificial gastric fluid, artificial intestinal fluid, artificial saliva, artificial rectal fluid Free drug in systemic circulation Blood level time profile, Peak blood level, Time to reach peak, Area under blood level time curve In vivo: whole blood, plasma, serum Pharmacologic effectOnset of effect, Duration of effect, Intensity of effect In vivo: discriminate measurement of pharmacologic effect (blood pressure, blood sugar, blood coagulation time) Clinical responseControlled clinical blind or double- blind, Observed clinical success or failure In vivo: evaluation of clinical responses EliminationCumulative amount of drug excreted, Maximum excretion rate, Peak time of excretion In vivo: urine